"Robust Immune Responses": Indian Vaccine-Maker After Test On Monkeys

PUBLISHED ON: September 12, 2020 | Duration: 0 min, 43 sec

  
loading..
Bharat Biotech that is developing the coronavirus vaccine COVAXIN in its latest report has said an animal study has shown a vaccine candidate has helped develop a strong immune response to the highly infectious coronavirus. "To summarise, the vaccine candidate was found to generate robust immune responses. Thus, preventing infection and disease in the primates upon high amounts of exposure to live SARS-CoV-2 virus," Bharat Biotech posted on its website.
ALSO WATCH
India's Covid Tally At 80.88 Lakh; 48,648 New Cases, 563 Deaths In A Day

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com